• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    What Stocks Does 'The Big Short' Investor Michael Burry Own?

    3/9/22 10:35:03 AM ET
    $BMY
    $CXW
    $FNF
    $GD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate
    Get the next $BMY alert in real time by email

    Michael Burry is the founder and former hedge fund manager of now-defunct Scion Capital, most famously known for his massively profitable contrarian investment in the events leading up to the collapse of the real estate market and subsequently the global financial crisis in 2008.

    Burry was active on Twitter (NYSE:TWTR) in 2021 until he closed his bearish bets on Tesla (NASDAQ:TSLA). He has since deleted his tweets, and his account. He is the hedge fund manager at Scion Asset Management.

    Though he has not been publicly active in 2022, "The Big Short" investor is keeping it short by holding only six positions in his current fund. According to a 13F and fund filings from Feb. 14, Scion Asset holds:

    Bridges Impact Corp (NYSE:IMPX) 

    • Shares: 1,000,000
    • Value: $9,910,991 
    • Bio: SPAC bringing Harley Davidson's Wire electric motorcycle public. 

    The GEO Group (NYSE:GEO) 

    • Shares: 850,000
    • Value: $4,794,000
    • Bio: real estate investment trust. 

    Corecivic Inc (NYSE:CXW)

    • Shares: 555,427
    • Value: $4,665,586
    • Bio: manages private prisons and detention centers. 

    Fidelity National Financial Inc (NYSE:FNF) 

    • Shares: 325,000
    • Value: $14,820,000
    • Bio: provider of title insurance and settlement services. 

    Bristol-Myers Squibb Co (NYSE:BMY) 

    • Shares: 300,000
    • Value: $20,322,000
    • Bio: multinational pharmaceutical company. 

    General Dynamics Corporation (NYSE:GD)

    • Shares: 80,000
    • Value: $18,824,800
    • Bio: aerospace and defense corporation. 
    Get the next $BMY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BMY
    $CXW
    $FNF
    $GD

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    1/30/2026$150.00 → $145.00Underweight
    Analyst
    Tesla Inc.
    $TSLA
    1/12/2026$120.00 → $130.00Underweight
    Wells Fargo
    Bristol-Myers Squibb Company
    $BMY
    1/7/2026$65.00Neutral → Buy
    UBS
    Tesla Inc.
    $TSLA
    1/2/2026$444.00 → $439.00Hold
    Truist
    General Dynamics Corporation
    $GD
    12/16/2025$408.00Equal-Weight → Overweight
    Morgan Stanley
    Bristol-Myers Squibb Company
    $BMY
    12/15/2025$61.00Neutral → Buy
    BofA Securities
    General Dynamics Corporation
    $GD
    12/12/2025$371.00Neutral
    Citigroup
    Bristol-Myers Squibb Company
    $BMY
    12/12/2025$62.00Neutral → Buy
    Guggenheim
    More analyst ratings

    $BMY
    $CXW
    $FNF
    $GD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chf Info & Digital Ofcr Groschen Laura A was granted 50,968 shares (SEC Form 4)

    4 - CoreCivic, Inc. (0001070985) (Issuer)

    2/3/26 4:41:14 PM ET
    $CXW
    Real Estate Investment Trusts
    Real Estate

    EVP, Chief Digital & Tech Off. Meyers Gregory Scott converted options into 2,543 shares and covered exercise/tax liability with 833 shares, increasing direct ownership by 9% to 21,428 units (SEC Form 4)

    4 - BRISTOL MYERS SQUIBB CO (0000014272) (Issuer)

    2/3/26 4:40:10 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President, RayzeBio Org. Hickey Benjamin converted options into 10,079 shares and covered exercise/tax liability with 3,810 shares, increasing direct ownership by 71% to 15,058 units (SEC Form 4)

    4 - BRISTOL MYERS SQUIBB CO (0000014272) (Issuer)

    2/3/26 4:39:19 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMY
    $CXW
    $FNF
    $GD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Fidelity National Financial Announces Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    JACKSONVILLE, Fla., Feb. 5, 2026 /PRNewswire/ -- Fidelity National Financial, Inc. (NYSE:FNF) (FNF), a leading provider of title insurance and transaction services to the real estate and mortgage industries and a leading provider of insurance solutions serving retail annuity and life customers and institutional clients through its majority-owned, publicly traded subsidiary F&G Annuities & Life, Inc. (NYSE:FG) (F&G), will release fourth quarter and full year 2025 earnings after the close of regular market trading on Thursday, February 19, 2026. A webcast and conference call to discuss the results will follow at 11:00 a.m. Eastern Time on Friday, February 20, 2026. Additional information abou

    2/5/26 4:15:00 PM ET
    $FG
    $FNF
    Life Insurance
    Finance
    Specialty Insurers

    Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025

    Bristol Myers Squibb (NYSE:BMY) today reported fourth quarter and full-year 2025 financial results. Visit the company's Investor Relations website at http://investor.bms.com to view the detailed fourth quarter and full-year 2025 earnings press release and investor presentation. The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, February 5, 2026, which is accessible here. Company executives will review financial results with the investment community during the call. A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes. About Bristol Myers Squibb:

    2/5/26 6:59:00 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    OXB Signs New Multi-Year Commercial Supply Agreement with Bristol Myers Squibb

    OXB to become commercial manufacturer of lentiviral vectors for Bristol Myers Squibb (BMS) CAR-T programmesMulti-year agreement with five-year initial term and option to extend Oxford, UK – 4 February 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has expanded its strategic partnership with Bristol Myers Squibb ("BMS") (NYSE:BMY), signing a new Commercial Supply Agreement (CSA) for the manufacture and supply of lentiviral vectors for BMS' CAR-T programmes. This expanded partnership builds on the existing relationship with Bristol Myers Squibb, originally announced in March 2020. Under the new agreement, OXB is expected to commence

    2/4/26 7:00:00 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMY
    $CXW
    $FNF
    $GD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst reiterated coverage on Tesla with a new price target

    Analyst reiterated coverage of Tesla with a rating of Underweight and set a new price target of $145.00 from $150.00 previously

    1/30/26 8:00:23 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Wells Fargo reiterated coverage on Tesla with a new price target

    Wells Fargo reiterated coverage of Tesla with a rating of Underweight and set a new price target of $130.00 from $120.00 previously

    1/12/26 9:31:17 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Bristol-Myers upgraded by UBS with a new price target

    UBS upgraded Bristol-Myers from Neutral to Buy and set a new price target of $65.00

    1/7/26 8:28:35 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMY
    $CXW
    $FNF
    $GD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Musk Elon bought $999,959,042 worth of shares (2,568,732 units at $389.28) (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    9/15/25 6:01:19 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    EVP,Chief Med.Offr.,Drug Dev. Hirawat Samit bought $202,215 worth of shares (4,250 units at $47.58), increasing direct ownership by 5% to 83,513 units (SEC Form 4)

    4 - BRISTOL MYERS SQUIBB CO (0000014272) (Issuer)

    4/29/25 6:14:13 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Gebbia Joseph bought $1,025,232 worth of shares (4,000 units at $256.31) (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    4/28/25 6:45:17 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $BMY
    $CXW
    $FNF
    $GD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 26, 2024 - FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

    For Immediate Release: September 26, 2024 Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.   “Schizophrenia is a leading

    9/26/24 6:42:20 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 14, 2024 - FDA Roundup: June 14, 2024

    For Immediate Release: June 14, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a proposed exemption for certain cottage cheese products from the requirements of the Food Traceability Rule. The proposal would exempt Grade “A” cottage cheese that appears on the Interstate Milk Shippers List from the requirements of the r

    6/14/24 3:54:45 PM ET
    $MMSI
    $BMY
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    March 8, 2024 - FDA Roundup: March 8, 2024

    For Immediate Release: March 08, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced proposed new regulations to provide animal drug sponsors with predictable requirements for the labeling of prescription and over-the-counter new animal drugs, as well as new animal drugs for use in animal feeds. The proposed content and

    3/8/24 3:26:46 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMY
    $CXW
    $FNF
    $GD
    SEC Filings

    View All

    SEC Form 10-K filed by Bristol-Myers Squibb Company

    10-K - BRISTOL MYERS SQUIBB CO (0000014272) (Filer)

    2/11/26 11:35:11 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bristol-Myers Squibb Company filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - BRISTOL MYERS SQUIBB CO (0000014272) (Filer)

    2/5/26 7:07:45 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by CoreCivic Inc.

    SCHEDULE 13G/A - CoreCivic, Inc. (0001070985) (Subject)

    1/30/26 1:30:14 PM ET
    $CXW
    Real Estate Investment Trusts
    Real Estate

    $BMY
    $CXW
    $FNF
    $GD
    Leadership Updates

    Live Leadership Updates

    View All

    Scientists Pointing to Hidden Power Source That Could Reshape Future of AI

    This article has been disseminated on behalf of MAX Power Mining Corp. and may include a paid advertisement. AUSTIN, Texas, Dec. 03, 2025 (GLOBE NEWSWIRE) -- MiningNewsWire: Global electricity demand is reaching a pivotal turning point. The International Energy Agency (IEA) now projects that global data-center electricity use will almost double by 2030, with AI-focused facilities increasing their consumption more than four times over the same span — a trajectory pushing power grids in the United States, China, Europe, Southeast Asia and other regions to their limits. The bottleneck is no longer data throughput or semiconductor performance; the critical constraint has become electricity it

    12/3/25 8:30:00 AM ET
    $AMZN
    $AVGO
    $META
    Catalog/Specialty Distribution
    Consumer Discretionary
    Semiconductors
    Technology

    Global Threat Surge Leads to $2.7T Defense Spending Boom and Institutional Rush

    Equity Insider News Commentary Issued on behalf of VisionWave Holdings, Inc. VANCOUVER, BC, Sept. 26, 2025 /PRNewswire/ -- Global military spending hit a record $2.7 trillion in 2024, marking a 9.4% surge that represents the steepest year-over-year increase in at least three decades as nations respond to "intensifying wars and rising geopolitical tensions worldwide," according to UN report[1]. NATO's updated defense expenditure data released in August confirms all 32 allies are expected to meet the 2% GDP spending target this year, while the alliance's commitment to reach 5% of GDP by 2035 creates unprecedented demand for advanced military technologies and platforms[2]. This defense spending

    9/26/25 10:30:00 AM ET
    $GD
    $LHX
    $LMT
    Marine Transportation
    Industrials
    Industrial Machinery/Components
    Military/Government/Technical

    IPX1031 Builds on Legacy of Excellence with New Manager of Banking Operations

    IPX1031 Names Joanna Panagopoulos as Banking Operations Manager CHICAGO, Sept. 11, 2025 /PRNewswire/ -- Investment Property Exchange Services, Inc. (IPX1031), the national leader in 1031 Qualified Intermediary services, is pleased to announce the appointment of Joanna Panagopoulos, CPA, as Vice President, Banking Operations Manager. With more than a decade of experience with IPX1031 in corporate finance, reconciliations, and operations management, Joanna Panagopoulos brings a strong track record of precision, leadership, and strategic oversight. In her new role at IPX1031, she

    9/11/25 10:00:00 AM ET
    $FNF
    Specialty Insurers
    Finance

    $BMY
    $CXW
    $FNF
    $GD
    Financials

    Live finance-specific insights

    View All

    Fidelity National Financial Announces Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    JACKSONVILLE, Fla., Feb. 5, 2026 /PRNewswire/ -- Fidelity National Financial, Inc. (NYSE:FNF) (FNF), a leading provider of title insurance and transaction services to the real estate and mortgage industries and a leading provider of insurance solutions serving retail annuity and life customers and institutional clients through its majority-owned, publicly traded subsidiary F&G Annuities & Life, Inc. (NYSE:FG) (F&G), will release fourth quarter and full year 2025 earnings after the close of regular market trading on Thursday, February 19, 2026. A webcast and conference call to discuss the results will follow at 11:00 a.m. Eastern Time on Friday, February 20, 2026. Additional information abou

    2/5/26 4:15:00 PM ET
    $FG
    $FNF
    Life Insurance
    Finance
    Specialty Insurers

    Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025

    Bristol Myers Squibb (NYSE:BMY) today reported fourth quarter and full-year 2025 financial results. Visit the company's Investor Relations website at http://investor.bms.com to view the detailed fourth quarter and full-year 2025 earnings press release and investor presentation. The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, February 5, 2026, which is accessible here. Company executives will review financial results with the investment community during the call. A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes. About Bristol Myers Squibb:

    2/5/26 6:59:00 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    General Dynamics Reports Fourth-Quarter and Full-Year 2025 Financial Results

    Fourth-quarter net earnings of $1.1 billion, diluted EPS of $4.17, on $14.4 billion in revenueFull-year net earnings of $4.2 billion, diluted EPS of $15.45, on $52.6 billion in revenue$1.6 billion cash provided by operating activities in the quarter, 137% of net earnings$1.2 billion in capital expenditures for the year, up 27% from 2024Book-to-bill of 1.6x in the quarter and 1.5x for the full year, ending the year with $118 billion in backlogRESTON, Va., Jan. 28, 2026 /PRNewswire/ -- General Dynamics (NYSE:GD) today reported quarterly net earnings of $1.1 billion on revenue of $14.4 billion. Diluted earnings per share (EPS) was $4.17. For the full year, net earnings were $4.2 billion, up 11.

    1/28/26 7:00:00 AM ET
    $GD
    Marine Transportation
    Industrials

    $BMY
    $CXW
    $FNF
    $GD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CoreCivic Inc.

    SC 13G - CoreCivic, Inc. (0001070985) (Subject)

    11/20/24 1:32:27 PM ET
    $CXW
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G filed by Geo Group Inc REIT

    SC 13G - GEO GROUP INC (0000923796) (Subject)

    11/12/24 9:55:15 AM ET
    $GEO
    Homebuilding
    Consumer Discretionary

    SEC Form SC 13D/A filed by General Dynamics Corporation (Amendment)

    SC 13D/A - GENERAL DYNAMICS CORP (0000040533) (Subject)

    4/10/24 4:41:27 PM ET
    $GD
    Marine Transportation
    Industrials